Cargando…

NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells

Natural Killer (NK) cells act as important regulators in the development and progression of hematological malignancies and their suppressor activity against Multiple Myeloma (MM) cells has been confirmed in many studies. Significant changes in the distribution of NK cell subsets and dysfunctions of...

Descripción completa

Detalles Bibliográficos
Autores principales: Petillo, Sara, Sproviero, Elena, Loconte, Luisa, Cuollo, Lorenzo, Zingoni, Alessandra, Molfetta, Rosa, Fionda, Cinzia, Soriani, Alessandra, Cerboni, Cristina, Petrucci, Maria Teresa, Fazio, Francesca, Paolini, Rossella, Santoni, Angela, Cippitelli, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352239/
https://www.ncbi.nlm.nih.gov/pubmed/37460534
http://dx.doi.org/10.1038/s41419-023-05949-z
_version_ 1785074468029202432
author Petillo, Sara
Sproviero, Elena
Loconte, Luisa
Cuollo, Lorenzo
Zingoni, Alessandra
Molfetta, Rosa
Fionda, Cinzia
Soriani, Alessandra
Cerboni, Cristina
Petrucci, Maria Teresa
Fazio, Francesca
Paolini, Rossella
Santoni, Angela
Cippitelli, Marco
author_facet Petillo, Sara
Sproviero, Elena
Loconte, Luisa
Cuollo, Lorenzo
Zingoni, Alessandra
Molfetta, Rosa
Fionda, Cinzia
Soriani, Alessandra
Cerboni, Cristina
Petrucci, Maria Teresa
Fazio, Francesca
Paolini, Rossella
Santoni, Angela
Cippitelli, Marco
author_sort Petillo, Sara
collection PubMed
description Natural Killer (NK) cells act as important regulators in the development and progression of hematological malignancies and their suppressor activity against Multiple Myeloma (MM) cells has been confirmed in many studies. Significant changes in the distribution of NK cell subsets and dysfunctions of NK cell effector activities were described in MM patients and correlated with disease staging. Thus, restoring or enhancing the functionality of these effectors for the treatment of MM represents a critical need. Neddylation is a post-translational modification that adds a ubiquitin-like molecule, NEDD8, to the substrate protein. One of the outcomes is the activation of the Cullin Ring Ligases (CRLs), a class of ubiquitin-ligases that controls the degradation of about 20% of proteasome-regulated proteins. Overactivation of CRLs has been described in cancer and can lead to tumor growth and progression. Thus, targeting neddylation represents an attractive approach for cancer treatment. Our group has recently described how pharmacologic inhibition of neddylation increases the expression of the NKG2D activating receptor ligands, MICA and MICB, in MM cells, making these cells more susceptible to NK cell degranulation and killing. Here, we extended our investigation to the direct role of neddylation on NK cell effector functions exerted against MM. We observed that inhibition of neddylation enhanced NK cell-mediated degranulation and killing against MM cells and improved Daratumumab/Elotuzumab-mediated response. Mechanistically, inhibition of neddylation increased the expression of Rac1 and RhoA GTPases in NK cells, critical mediators for an efficient degranulation at the immunological synapse of cytotoxic lymphocytes, and augmented the levels of F-actin and perforin polarization in NK cells contacting target cells. Moreover, inhibition of neddylation partially abrogated TGFβ-mediated repression of NK cell effector activity. This study describes the role of neddylation on NK cell effector functions and highlights the positive immunomodulatory effects achieved by the inhibition of this pathway in MM.
format Online
Article
Text
id pubmed-10352239
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-103522392023-07-19 NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells Petillo, Sara Sproviero, Elena Loconte, Luisa Cuollo, Lorenzo Zingoni, Alessandra Molfetta, Rosa Fionda, Cinzia Soriani, Alessandra Cerboni, Cristina Petrucci, Maria Teresa Fazio, Francesca Paolini, Rossella Santoni, Angela Cippitelli, Marco Cell Death Dis Article Natural Killer (NK) cells act as important regulators in the development and progression of hematological malignancies and their suppressor activity against Multiple Myeloma (MM) cells has been confirmed in many studies. Significant changes in the distribution of NK cell subsets and dysfunctions of NK cell effector activities were described in MM patients and correlated with disease staging. Thus, restoring or enhancing the functionality of these effectors for the treatment of MM represents a critical need. Neddylation is a post-translational modification that adds a ubiquitin-like molecule, NEDD8, to the substrate protein. One of the outcomes is the activation of the Cullin Ring Ligases (CRLs), a class of ubiquitin-ligases that controls the degradation of about 20% of proteasome-regulated proteins. Overactivation of CRLs has been described in cancer and can lead to tumor growth and progression. Thus, targeting neddylation represents an attractive approach for cancer treatment. Our group has recently described how pharmacologic inhibition of neddylation increases the expression of the NKG2D activating receptor ligands, MICA and MICB, in MM cells, making these cells more susceptible to NK cell degranulation and killing. Here, we extended our investigation to the direct role of neddylation on NK cell effector functions exerted against MM. We observed that inhibition of neddylation enhanced NK cell-mediated degranulation and killing against MM cells and improved Daratumumab/Elotuzumab-mediated response. Mechanistically, inhibition of neddylation increased the expression of Rac1 and RhoA GTPases in NK cells, critical mediators for an efficient degranulation at the immunological synapse of cytotoxic lymphocytes, and augmented the levels of F-actin and perforin polarization in NK cells contacting target cells. Moreover, inhibition of neddylation partially abrogated TGFβ-mediated repression of NK cell effector activity. This study describes the role of neddylation on NK cell effector functions and highlights the positive immunomodulatory effects achieved by the inhibition of this pathway in MM. Nature Publishing Group UK 2023-07-17 /pmc/articles/PMC10352239/ /pubmed/37460534 http://dx.doi.org/10.1038/s41419-023-05949-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Petillo, Sara
Sproviero, Elena
Loconte, Luisa
Cuollo, Lorenzo
Zingoni, Alessandra
Molfetta, Rosa
Fionda, Cinzia
Soriani, Alessandra
Cerboni, Cristina
Petrucci, Maria Teresa
Fazio, Francesca
Paolini, Rossella
Santoni, Angela
Cippitelli, Marco
NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells
title NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells
title_full NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells
title_fullStr NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells
title_full_unstemmed NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells
title_short NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells
title_sort nedd8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352239/
https://www.ncbi.nlm.nih.gov/pubmed/37460534
http://dx.doi.org/10.1038/s41419-023-05949-z
work_keys_str_mv AT petillosara nedd8activatingenzymeinhibitionpotentiatestheantimyelomaactivityofnaturalkillercells
AT sprovieroelena nedd8activatingenzymeinhibitionpotentiatestheantimyelomaactivityofnaturalkillercells
AT loconteluisa nedd8activatingenzymeinhibitionpotentiatestheantimyelomaactivityofnaturalkillercells
AT cuollolorenzo nedd8activatingenzymeinhibitionpotentiatestheantimyelomaactivityofnaturalkillercells
AT zingonialessandra nedd8activatingenzymeinhibitionpotentiatestheantimyelomaactivityofnaturalkillercells
AT molfettarosa nedd8activatingenzymeinhibitionpotentiatestheantimyelomaactivityofnaturalkillercells
AT fiondacinzia nedd8activatingenzymeinhibitionpotentiatestheantimyelomaactivityofnaturalkillercells
AT sorianialessandra nedd8activatingenzymeinhibitionpotentiatestheantimyelomaactivityofnaturalkillercells
AT cerbonicristina nedd8activatingenzymeinhibitionpotentiatestheantimyelomaactivityofnaturalkillercells
AT petruccimariateresa nedd8activatingenzymeinhibitionpotentiatestheantimyelomaactivityofnaturalkillercells
AT faziofrancesca nedd8activatingenzymeinhibitionpotentiatestheantimyelomaactivityofnaturalkillercells
AT paolinirossella nedd8activatingenzymeinhibitionpotentiatestheantimyelomaactivityofnaturalkillercells
AT santoniangela nedd8activatingenzymeinhibitionpotentiatestheantimyelomaactivityofnaturalkillercells
AT cippitellimarco nedd8activatingenzymeinhibitionpotentiatestheantimyelomaactivityofnaturalkillercells